Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Scientific Session

Pediatric Autoimmune Arthritis: Juvenile Inflammatory Arthritis, Juvenile Spondyloarthritis (SpA), etc.

Session: Promoting Comparative Effectiveness Research in Pediatric Rheumatology: The Challenges of Making Consensus Treatment Plans Work

Panel Discussion

Tuesday, October 28, 2025
11:00 AM - 11:30 AM Central Time
CE: 1.5

    Panelist(s)

  • SA

    Stacy Ardoin, MD;MSc

    Nationwide Children's Hospital
    Columbus, OH, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • ST

    Stacey Tarvin, MD;MS;FACR

    Riley Hospital for Children at Indiana University
    Indianapolis, IN, United States

    Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); American Academy of Pediatrics: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Grant/Research Support (Ongoing); Arthritis Foundation: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Childhood Arthritis Rheumatology Research Alliance: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Terminated, April 1, 2026); Rheumatology Research Foundation: Grant/Research Support (Ongoing); Roche: Grant/Research Support (Ongoing); UCB: Grant/Research Support (Ongoing)

  • CY

    Cagri Yildirim-Toruner, MD

    Baylor College of Medicine/ Texas Children's Hospital
    Houston, TX, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose